Turnbridge Capital
Turnbridge Capital, LLC is a private equity firm founded in 2008 and headquartered in Dallas, Texas, with an additional office in Houston. The firm specializes in management buyouts, corporate spinouts, leveraged build-ups, and strategic growth capital infusions, primarily targeting middle-market and emerging growth companies. Focused on sectors such as energy and infrastructure, industrial manufacturing, transportation, and distribution, Turnbridge Capital seeks to invest between $25 million and $100 million in companies with enterprise values ranging from $50 million to $250 million. The firm aims to maintain majority ownership in its portfolio companies and typically holds investments for three to seven years, depending on individual circumstances. Turnbridge Capital employs its personal capital for investments and concentrates its efforts primarily in North America, particularly in the southwestern United States.
Gradiant Energy Services
Venture Round in 2017
Gradiant Energy Services, Inc. is an oilfield services company focused on addressing the water challenges faced by the oil and gas industry. Founded in 2012 and headquartered in Denver, Colorado, with a regional office in Midland, Texas, the company offers a range of water treatment solutions, including bacteria treatment, reusable clean brine, evaporative disposal, and freshwater/desalination and brine collection. Gradiant Energy Services caters to oil and gas exploration and production operators who require effective treatment, reuse, and recycling of flowback and produced water. The company's custom-engineered solutions and innovative technologies aim to provide safe, reliable, and environmentally efficient services to its clients in the Permian and Marcellus shale plays.
Cimarron Energy
Acquisition in 2014
Cimarron Energy Inc is a company specializing in the engineering and manufacturing of emissions control solutions aimed at reducing greenhouse gas emissions across various industries. The company produces a range of equipment, including vapor recovery units, combustors, and other systems designed to manage and mitigate emissions. In addition to its manufacturing capabilities, Cimarron Energy provides compliance services and maintains safety plans, demonstrating its commitment to regulatory adherence. The company has also expanded its market presence through strategic acquisitions, such as Hy-Bon/EDI, which enhances its expertise in vapor recovery and emissions control. With over three decades of experience, Cimarron Energy is recognized for its innovative engineering approach and dedication to quality, ensuring that its products meet the specific needs of customers in the oil and gas sector while promoting environmentally responsible practices.
Morphotek
Series B in 2001
Morphotek, established in 2000, is a prominent life science company specializing in developing novel biological products to combat cancer, inflammation, and infectious diseases. The company's core technology, morphogenics, was co-invented by its current President and CEO, Dr. Nicholas Nicolaides, during his postgraduate research at Johns Hopkins Medical School. Morphotek focuses on discovering and developing monoclonal antibodies (mAbs) using this proprietary technology to treat various conditions such as ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The company conducts independent research and clinical development programs for its drug candidates.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.